The 13 most recent market catalysts affecting $IMCC, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 23, 2026
Corporate Catalyst
Bullish
Impact 65
IM Cannabis Says It Received Nasdaq Notice Of Regained Compliance With Minimum Bid Price Rule
This headline indicates that IM Cannabis has successfully addressed a critical compliance issue with Nasdaq, specifically the minimum bid price rule. This removes the immediate thr…
Sep 23, 2026
Corporate Catalyst
Bearish
Impact 85
IM Cannabis Stock Falls after $1.31 Million Offering Follows Drone Deal
IM Cannabis announced two significant events: a $1.31 million registered direct offering and a non-binding agreement to acquire 51% of Space Defense Innovations, a company focused …
Sep 23, 2026
Corporate Catalyst
Bullish
Impact 65
IMCC stock has given up its prior gain. IM Cannabis shares were trading higher after the company announced it will acquire a 51% stake in Space Defense Innovations.
The headline indicates a corporate catalyst – an acquisition – which initially spurred positive sentiment for IMCC. However, the subsequent 'giving up of prior gain' suggests that …
Sep 23, 2026
Market Technicals
Bullish
Impact 55
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
This SEC 8-K filing, generated by Benzinga, reports on the pre-market trading activity of 12 health care stocks, highlighting both significant gainers and losers. While the filing …
Sep 23, 2026
Corporate Catalyst
Bullish
Impact 75
IM Cannabis shares are trading higher after the company announced it will acquire a 51% stake in Space Defense Innovations.
This headline signals a significant corporate catalyst for IM Cannabis, as acquiring a majority stake in another company can lead to substantial changes in revenue, market share, a…
Sep 18, 2026
Market Technicals
Bullish
Impact 55
12 Health Care Stocks Moving In Friday's Intraday Session
This 8-K filing, while presented as an SEC filing, is actually a Benzinga article summarizing intraday stock performance for a selection of health care companies. It highlights sig…
Aug 28, 2026
Corporate Catalyst
Bearish
Impact 75
IM Cannabis shares are trading lower after the company's common shares commenced trading on the Nasdaq on a 30:1 post-consolidated basis.
The reverse stock split (30:1 consolidation) itself is a significant corporate action, often viewed negatively by the market as it can indicate a company struggling to maintain its…
Aug 27, 2026
Corporate Catalyst
Neutral
Impact 65
IM Cannabis Shares Start Trading On 30-For-1 Split Basis
IM Cannabis Corp. has implemented a 30-for-1 reverse stock split, meaning shareholders now own one share for every thirty previously held, with the share price theoretically increa…
Aug 18, 2026
Corporate Catalyst
Neutral
Impact 65
IM Cannabis To Complete 30-To-1 Share Consolidation On Or Before September 15, 2026
IM Cannabis Corp. is implementing a 30-to-1 share consolidation, a corporate action where the number of outstanding shares is reduced, and the price per share is proportionally inc…
Aug 17, 2026
Corporate Catalyst
Bullish
Impact 75
IM Cannabis Leverages Restructuring Deal to Reduce Financial Strain
IM Cannabis is undergoing a significant restructuring by selling its IMC Holdings Ltd. subsidiary to a related party, Slil.com Holding Ltd., controlled by its CEO. This move is int…
Aug 17, 2026
Corporate Catalyst
Bearish
Impact 75
IM Cannabis shares are trading lower after the company announced that it's selling some subsidiary companies excluding Israeli assets to Slil.com for approximately C$3 million.
This headline indicates a significant corporate restructuring for IM Cannabis, divesting non-core assets. The low sale price of C$3 million for 'some subsidiary companies' suggests…
Aug 17, 2026
Corporate Catalyst
Bullish
Impact 65
IM Cannabis Agrees To Sell IMC Holdings And European Focused Assets to Slil; Transaction Expected to Improve Shareholders' Equity by of Approximately C$3M
IM Cannabis (IMCC) has entered into a definitive agreement to sell its European-focused assets, held under IMC Holdings, to Slil.com Holding Ltd. This strategic divestiture is sign…
Aug 13, 2026
Corporate Catalyst
Bearish
Impact 95
IM Cannabis Q2 EPS $(0.34) Down From $(0.07) YoY, Sales $5.482M Down From $9.172M YoY
IM Cannabis reported a substantial deterioration in its Q2 financial performance, with EPS losses widening by 385.71% and sales decreasing by 40.23% year-over-year. This indicates …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.